placeholder newsslider

The European Vision Institute EEIG

European Alliance for the Promotion of Vision Research and Ophthalmology

Blindness is one of the most feared health hazards in our present society; millions of Europeans are threatened by blinding untreatable eye diseases producing costs of several billion Euros. EVI aims at devising and implementing programs and projects for new therapeutic strategies for eye diseases that are difficult or impossible to be treated presently. Its approach will incorporate the most recent scientific developments of the postgenomic area.

The Importance of EVI

The European Vision Institute should be of enormous strategic importance for the future and is targeted towards more immediate policy objectives of improving the competitiveness of European Research assembling the top institutes together with partners from industry and academia. EVI integrates, conducts and supports research that helps to prevent and treat eye diseases and other disorders of vision. This research leads to sight-saving treatments, reduces visual impairment and blindness, and improves the quality of life for people of all ages.

Vision Research in Europe

New Technologies for Outcome Measures in Uveal Melanoma

Basel Series of Special Interest Focus Groups (SIFG) - „New Technologies for Outcome Measures in Uveal Melanoma” In Collaboration with the European Ocular Oncology Group and the International Society of Ocular Oncology Read more

Closer Collaboration between EC and European Union Intellectual Property Office

The Commission and the European Union Intellectual Property Office commit to closer collaboration on Intellectual Property to support the market uptake of research results Read more

First Place of the OSA2021

Congratulations! After having won the Swiss OpthAward 2021, Magdalena Renner, Head of the IOB Human Organoid Platform won the first place of the VSY Biotechnology Ophthalmology Star Awards (OSA) 2021. Read more

Turkey joins the Horizon Europe, Erasmus+ and Solidarity Corps programmes

The Commission and Turkey signed three agreements granting association status to EU programmes for the period 2021-2027 Read more

Optimism Health Group Expands its Footprint with VisionCall acquisition

Optimism Health Group, a healthcare investment business, has recently completed the acquisition of VisionCall, the UK's leading provider of eye care services in care homes. The acquisition came in line with Optimism’s plans to expand its footprint in the fast-growing market for healthcare products... Read more

vision-research.eu

The "Gateway to European Vision Research" is a web-based portal service for the European vision research community and major stakeholders.

The Vision Awards

An award and public recognition by any measure is a sign of inimitability - an acknowledgment that peers and professionals alike agree that a certain person excels in what they do.

Read more about the European Vision Award and the Carl Zeiss Young Investigator Award.

Ophthalmic Research

Ophthalmic Research - The Journal for Translational and Clinical Research is official affiliated with the European Vision Institute

Basel Series of Special Interest Focus Groups